» Articles » PMID: 25734085

High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care?

Overview
Date 2015 Mar 4
PMID 25734085
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The "cascade of care" displays the proportion of individuals who are infected with human immunodeficiency virus (HIV), diagnosed, linked, retained, on antiretroviral treatment, and HIV suppressed. We examined the implications of including death in the use of this cascade for program and public health performance metrics.

Methods: Individuals newly diagnosed with HIV and living in Calgary between 2006 and 2013 were included. Through linkage with Public Health and death registries, the deaths (ie, all-cause mortality) and their distribution within the cascade were determined. Mortality rates are reported per 100 person-years.

Results: Estimated new HIV infections were 680 (543 confirmed and 137 unknown cases). Forty-three individuals, after diagnosis, were never referred for HIV care. Despite referral(s), 88 individuals (18%) never attended the clinic for HIV care. Of individuals retained in care, 87% received antiretroviral therapy and 76% achieved viral suppression. Thirty-six deaths were reported (mortality rate, 1.50/100 person-years). One diagnosis was made posthumously. Deaths (20 of 35; 57%) occurred for individuals linked but not retained in care (6.93/100 person-years), and 70% were HIV-related. Mortality rate for patients in care was 0.79/100 person-years. Retained patients with detectable viremia had a death rate of 2.49/100, which contrasted with 0.28/100 person-years in those with suppressed viremia. Eight of these 15 deaths (53%) were HIV-related.

Conclusions: Over half of deaths occurred in those referred but not effectively linked or retained in HIV care, and these cases may be easily overlooked in standard HIV mortality studies. Inclusion of deaths into the cascade may further enhance its value as a public health metric.

Citing Articles

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study.

Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K Lancet HIV. 2018; 5(6):e301-e308.

PMID: 29893243 PMC: 5990495. DOI: 10.1016/S2352-3018(18)30048-1.


Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care.

Ruadze E, Chkhartishvili N, Chokoshvili O, Tsertsvadze T SAGE Open Med. 2017; 5:2050312117731977.

PMID: 28975029 PMC: 5613841. DOI: 10.1177/2050312117731977.


Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers.

Grau L, Griffiths-Kundishora A, Heimer R, Hutcheson M, Nunn A, Towey C Addict Sci Clin Pract. 2017; 12(1):24.

PMID: 28965489 PMC: 5623965. DOI: 10.1186/s13722-017-0088-7.


Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia.

Heimer R, Usacheva N, Barbour R, Niccolai L, Uuskula A, Levina O Addiction. 2017; 112(8):1421-1431.

PMID: 28233356 PMC: 5526080. DOI: 10.1111/add.13798.


Prevalence and factors associated with occupational burnout among HIV/AIDS healthcare workers in China: a cross-sectional study.

Qiao Z, Chen L, Chen M, Guan X, Wang L, Jiao Y BMC Public Health. 2016; 16:335.

PMID: 27079376 PMC: 4832489. DOI: 10.1186/s12889-016-2890-7.


References
1.
Kilmarx P, Mutasa-Apollo T . Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS. 2012; 8(1):59-64. DOI: 10.1097/COH.0b013e32835b806e. View

2.
Alibhai A, Kipp W, Saunders L, Senthilselvan A, Kaler A, Houston S . Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health. 2010; 2:45-52. PMC: 2971741. DOI: 10.2147/ijwh.s9408. View

3.
Nosyk B, Montaner J, Colley G, Lima V, Chan K, Heath K . The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis. 2013; 14(1):40-49. PMC: 4017913. DOI: 10.1016/S1473-3099(13)70254-8. View

4.
Montaner J, Hogg R, Wood E, Kerr T, Tyndall M, Levy A . The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006; 368(9534):531-6. DOI: 10.1016/S0140-6736(06)69162-9. View

5.
Eberhart M, Yehia B, Hillier A, Voytek C, Blank M, Frank I . Behind the cascade: analyzing spatial patterns along the HIV care continuum. J Acquir Immune Defic Syndr. 2013; 64 Suppl 1:S42-51. PMC: 3891372. DOI: 10.1097/QAI.0b013e3182a90112. View